Patent infringement – meaning and scope MCQs With Answer

Patent infringement – meaning and scope MCQs With Answer is a focused quiz designed for M.Pharm students to strengthen their understanding of patent infringement concepts relevant to pharmaceuticals. This set covers fundamental definitions, types of infringement (direct, indirect, contributory), claim interpretation, the doctrine of equivalents, territoriality, experimental-use and regulatory exemptions (Bolar), and practical aspects such as claim charts, remedies and defenses. Questions integrate legal principles with pharmaceutical scenarios like generics development, process patents and importation. Going beyond basics, the quiz highlights how patent law interacts with drug development, validation and regulatory submissions, helping students develop practical skills for freedom-to-operate analyses and risk mitigation in pharmaceutical practice.

Q1. What is the most complete definition of patent infringement?

• Using a drug in a clinical trial without informed consent
• Unauthorized making, using, selling, offering to sell, or importing a patented invention within the patent’s jurisdiction without the patentee’s permission
• Filing a patent application that is similar to an existing patent
• Manufacturing a generic version of a drug after patent expiry

Correct Answer: Unauthorized making, using, selling, offering to sell, or importing a patented invention within the patent’s jurisdiction without the patentee’s permission

Q2. Which of the following best describes literal infringement?

• A court finding that a product performs substantially the same function as a claimed element
• When every element or limitation of a patent claim is found exactly in the accused product or process
• Supplying a single component used in a patented combination
• Using a patented invention for purely academic research

Correct Answer: When every element or limitation of a patent claim is found exactly in the accused product or process

Q3. The Doctrine of Equivalents addresses which situation?

• A patent claim that has expired and can be freely used
• A situation where the accused product does not literally meet claim terms but performs substantially the same function in substantially the same way to achieve the same result
• The geographic reach of a patent
• Only process claims and not product claims

Correct Answer: A situation where the accused product does not literally meet claim terms but performs substantially the same function in substantially the same way to achieve the same result

Q4. Which statement is true about process (method) patents in pharmaceuticals?

• Process patents automatically cover all products made by any method
• A product made by a patented process may infringe the process claim if the product is imported or sold in the patent jurisdiction
• Process patents cannot be enforced against manufacturers outside the country where the patent is granted
• Process claims expire earlier than product claims

Correct Answer: A product made by a patented process may infringe the process claim if the product is imported or sold in the patent jurisdiction

Q5. What is contributory infringement in the patent context?

• Directly practicing every claim element of a patent
• Supplying a material or component specially adapted for use in a patented invention, knowing it to be especially made for infringement and not suitable for substantial noninfringing use
• Filing a patent application for a derived invention
• Using a patent for experimental research only

Correct Answer: Supplying a material or component specially adapted for use in a patented invention, knowing it to be especially made for infringement and not suitable for substantial noninfringing use

Q6. The Hatch-Waxman/Bolar exemption generally allows what activity without constituting patent infringement?

• Commercial sale of a generic drug before patent expiry
• Using a patented invention solely to generate data for regulatory approval of a generic or biosimilar before patent expiry
• Exporting a patented drug to any country
• Manufacturing a patented drug in large scale for stockpiling during patent term

Correct Answer: Using a patented invention solely to generate data for regulatory approval of a generic or biosimilar before patent expiry

Q7. Patent rights are territorial. What does this mean?

• A granted patent automatically applies worldwide
• A patent is only enforceable within the country or jurisdiction that granted the patent
• Patents are valid only in the country where the inventor was born
• Once a patent is granted in one country it does not need to be filed elsewhere

Correct Answer: A patent is only enforceable within the country or jurisdiction that granted the patent

Q8. In most jurisdictions, who primarily determines the meaning of patent claim terms during infringement proceedings?

• The jury without guidance
• The patent office examiners after infringement proceedings
• The judge through claim construction (e.g., a Markman hearing in the U.S.)
• The defendant company’s R&D team

Correct Answer: The judge through claim construction (e.g., a Markman hearing in the U.S.)

Q9. Which remedy is commonly available to a successful patent holder in an infringement lawsuit?

• Compulsory licensing of the patentee’s other unrelated patents
• Injunctions to stop further infringement and monetary damages for past infringement
• Automatic criminal penalties for the infringer
• Extension of the patent term beyond statutory limits

Correct Answer: Injunctions to stop further infringement and monetary damages for past infringement

Q10. What is a common legal consequence of willful patent infringement?

• A reduction of the patent term
• Possibility of enhanced damages (e.g., up to treble damages) and adverse credibility findings
• Immediate invalidation of the patent
• Automatic settlement requirement

Correct Answer: Possibility of enhanced damages (e.g., up to treble damages) and adverse credibility findings

Q11. The patent exhaustion doctrine means:

• Patentees can control the use of sold products indefinitely
• A lawful sale of a patented product by the patent owner or with their authorization exhausts the patent owner’s rights to control that specific item’s further disposition
• Patents expire automatically upon first sale
• The patentee must re-register rights after each sale

Correct Answer: A lawful sale of a patented product by the patent owner or with their authorization exhausts the patent owner’s rights to control that specific item’s further disposition

Q12. Which of the following best describes patent linkage in the pharmaceutical regulatory context?

• A system that links patent term to the active pharmaceutical ingredient’s market price
• A regulatory mechanism where marketing approval for generics is linked to the patent status of the reference product, often delaying approval until patent issues are addressed
• A requirement that all patents be listed publicly for academic review
• A method for combining multiple patents into a single mixed claim

Correct Answer: A regulatory mechanism where marketing approval for generics is linked to the patent status of the reference product, often delaying approval until patent issues are addressed

Q13. What is the primary purpose of a claim chart in patent litigation or FTO analysis?

• To display the stock prices of companies owning patents
• To map each claim element of a patent to features of an accused product or prior art, demonstrating presence or absence of infringement or invalidity
• To summarize patent prosecution history for the patent office
• To list all inventors and their contributions

Correct Answer: To map each claim element of a patent to features of an accused product or prior art, demonstrating presence or absence of infringement or invalidity

Q14. Induced infringement requires which key elements?

• The indirect supplier must be the owner of the patent
• There must be an act of direct infringement by a third party, and the inducer must have knowingly encouraged or aided that infringement with intent
• Only careless behavior is sufficient
• Induced infringement applies only to inventions outside pharmaceuticals

Correct Answer: There must be an act of direct infringement by a third party, and the inducer must have knowingly encouraged or aided that infringement with intent

Q15. Which defense is commonly raised by generics when accused of patent infringement during bioequivalence studies?

• Patent misuse by the innovator company
• Bolar or regulatory-approval exemption allowing use of patented inventions for tests and trials necessary for regulatory submissions
• That the patent owner never used the patent commercially
• That generics always have an implied license

Correct Answer: Bolar or regulatory-approval exemption allowing use of patented inventions for tests and trials necessary for regulatory submissions

Q16. For literal infringement of a claimed combination (compound or formulation), what is required?

• At least one claim element must be present in the accused product
• All claim elements or limitations must be present in the accused product or process as claimed
• Only the active ingredient needs to match
• That the accused product is in the same therapeutic class

Correct Answer: All claim elements or limitations must be present in the accused product or process as claimed

Q17. Which scenario best illustrates contributory infringement in the pharmaceutical context?

• A company sells a patented drug after obtaining a license
• A supplier sells a chemical intermediate that has no substantial noninfringing uses and is known to be destined for a patented process
• A university researcher uses a patented compound for publication-only studies
• A regulatory agency approves a generic drug

Correct Answer: A supplier sells a chemical intermediate that has no substantial noninfringing uses and is known to be destined for a patented process

Q18. When assessing equivalence under the function-way-result test, which factor is NOT part of the classic test?

• Whether the accused element performs substantially the same function as the claim element
• Whether the accused element operates in substantially the same way as the claim element
• Whether the accused element achieves substantially the same result as the claim element
• Whether the accused product was manufactured in the patentee’s country of origin

Correct Answer: Whether the accused product was manufactured in the patentee’s country of origin

Q19. How do product claims differ from process claims in practical enforcement?

• Product claims protect only manufacturing steps, while process claims protect the physical product
• Product claims can block others from making, using or selling the product regardless of how it was made; process claims protect the specific method steps used
• Process claims always provide broader protection than product claims
• There is no legal difference between product and process claims

Correct Answer: Product claims can block others from making, using or selling the product regardless of how it was made; process claims protect the specific method steps used

Q20. Which proactive measure best reduces the risk of patent infringement for a pharmaceutical company before product launch?

• Relying solely on public domain information without formal analysis
• Conducting a freedom-to-operate (FTO) search and legal opinion to identify relevant patents and design-around or license options
• Assuming patents are unenforceable in other countries
• Waiting until after launch to address patent concerns

Correct Answer: Conducting a freedom-to-operate (FTO) search and legal opinion to identify relevant patents and design-around or license options

Download